Participant | Orthostasis | Plasma levels† | Mutation associated with dopamine β hydroxylase deficiency syndrome | −1021 genotype | |||
---|---|---|---|---|---|---|---|
Norepinephrine (pg/ml) | Epinephrine (pg/ml) | Dopamine (pg/ml) | Dopamine β hydroxylase (U/l) | ||||
ND, not determined; C, C allele; T, T allele. | |||||||
* Participants with orthostatic hypotension boxed. | |||||||
† Normal values: <600 pg/ml for norepinephrine, <120 pg/ml for epinephrine, and <60 pg/ml for dopamine. | |||||||
A1.1 | No | 720 | 121 | 60 | 16.9 | Heterozygous IVS1+2T>C | TC |
A.1.2 | No | 439 | 32 | 45 | 0 | Heterozygous IVS1+2T>C | TT |
A2.1 | Yes | 0 | 0 | 480 | 0 | Homozygous IVS1+2T>C | TT |
A2.2 | No | 602 | 428 | 68 | 19.6 | ND | ND |
A2.3 | No | 184 | 112 | 27 | 0 | Heterozygous IVS1+2T>C | TT |
B1.1 | No | 117 | 19 | 31 | 0.8 | Heterozygous c.575delA | TC |
B1.2 | No | 244 | 91 | 23 | 21.3 | Heterozygous IVS1+2T>C | TC |
B2.1 | Yes | 0 | 0 | 250 | 0 | IVS1+2T>C/c.575delA | TC |
B2.2 | No | 195 | 78 | 12 | 14.2 | Heterozygous c.575delA | CC |
C1.1 | No | 231 | 18 | 5 | 9.2 | Heterozygous 764G>T | CC |
C1.2 | No | 187 | 45 | 4 | 19 | Heterozygous 764G>T | CC |
C2.1 | No | 231 | 11 | 44 | 9.8 | Heterozygous 764G>T | CC |
C2.2 | Yes | 0 | 7 | 77 | 0 | Homozygous 764G>T | CC |
C2.3 | No | 131 | 19 | 3 | 9.8 | Heterozygous 764G>T | CC |
D1.1 | No | 379 | 119 | 20 | 5.8 | Heterozygous 1625A>G | CC |
D1.2 | No | 430 | 59 | 14 | 0 | Heterozygous IVS1+2T>C | TT |
D2.1 | Yes | 20 | 72 | 205 | 0 | IVS1+2T>C/1625A>G | TC |
D2.2 | Yes | 0 | 10 | 51 | 0 | IVS1+2T>C/1625A>G | TC |
D2.3 | No | 235 | 23 | 10 | 5 | Heterozygous IVS1+2T>C | TC |
D2.4 | No | 293 | 35 | 10 | 7.1 | Heterozygous IVS1+2T>C | TC |
D2.5 | Yes | 5 | 0 | 114 | 0 | IVS1+2T>C/1625A>G | TC |